107 related articles for article (PubMed ID: 16557019)
1. [Use of Getah virus for antiviral assay of human interferon].
Ogiso S; Shirai J; Tuchiya Y; Honda E
Uirusu; 2005 Dec; 55(2):317-26. PubMed ID: 16557019
[TBL] [Abstract][Full Text] [Related]
2. Establishing a safe, rapid, convenient and low-cost antiviral assay of interferon bioactivity based on recombinant VSV expressing GFP.
Chen W; Wen Z; Zhang J; Li C; Huang K; Bu Z
J Virol Methods; 2018 Feb; 252():1-7. PubMed ID: 28834736
[TBL] [Abstract][Full Text] [Related]
3. Pegylation of IFN-alpha and antiviral activity.
Boulestin A; Kamar N; Sandres-Sauné K; Alric L; Vinel JP; Rostaing L; Izopet J
J Interferon Cytokine Res; 2006 Dec; 26(12):849-53. PubMed ID: 17238827
[TBL] [Abstract][Full Text] [Related]
4. A bioassay for interferon type I based on inhibition of Sendai virus growth.
Perler L; Pfister H; Schweizer M; Peterhans E; Jungi TW
J Immunol Methods; 1999 Jan; 222(1-2):189-96. PubMed ID: 10022385
[TBL] [Abstract][Full Text] [Related]
5. The calcium ionophore A23187 evokes and potentiates antiviral activity of interferon.
Maheshwari RK; Husain MM; Friedman RM; Krishna G
J Interferon Res; 1985; 5(4):605-12. PubMed ID: 2418129
[TBL] [Abstract][Full Text] [Related]
6. Post HCV Infection Due to MX Gene Stimulation Produced Post Treatment with Imported and Locally Produced Egyptian Biosimilar IFN.
Mohamed SH; Mahmoud NF; Mohamed AF; Kotb NS
Asian Pac J Cancer Prev; 2015; 16(14):5635-41. PubMed ID: 26320428
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of virus-induced protein kinase in the antiviral state induced with interferon-gamma against Sindbis virus.
Saito S
J Interferon Res; 1989 Feb; 9(1):23-34. PubMed ID: 2541209
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effects of recombinant human tumor necrosis factor.
Ito M; O'Malley JA
Lymphokine Res; 1987; 6(4):309-18. PubMed ID: 2448553
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined alpha IFN and prostaglandin A1 treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells.
Pica F; Rossi A; Santirocco N; Palamara A; Garaci E; Santoro MG
Antiviral Res; 1996 Mar; 29(2-3):187-98. PubMed ID: 8739598
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins.
Wallach D
J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250
[TBL] [Abstract][Full Text] [Related]
11. Effect of human interferon on vesicular stomatitis virus released from bovine embryonic kidney cells.
Harrell SA; Maheshwari RK; Mohanty SB; Friedman RM
Am J Vet Res; 1982 Apr; 43(4):565-8. PubMed ID: 6176154
[TBL] [Abstract][Full Text] [Related]
12. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C.
Cembrzyńska-Nowak M
Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cytotoxicity and antiviral activity of recombinant human interferon alfa-2a and recombinant human interferon alfa-B/D hybrid against bovine viral diarrhea virus, infectious bovine rhinotracheitis virus, and vesicular stomatitis virus in vitro.
Peek SF; Bonds MD; Gangemi DG; Thomas CB; Schultz RD
Am J Vet Res; 2004 Jun; 65(6):871-4. PubMed ID: 15198231
[TBL] [Abstract][Full Text] [Related]
14. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
[TBL] [Abstract][Full Text] [Related]
15. WISH cell line: from the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β.
Bürgi Mde L; Prieto C; Etcheverrigaray M; Kratje R; Oggero M; Bollati-Fogolín M
J Immunol Methods; 2012 Jul; 381(1-2):70-4. PubMed ID: 22549076
[TBL] [Abstract][Full Text] [Related]
16. Impaired antiviral response in human hepatoma cells.
Keskinen P; Nyqvist M; Sareneva T; Pirhonen J; Melén K; Julkunen I
Virology; 1999 Oct; 263(2):364-75. PubMed ID: 10544109
[TBL] [Abstract][Full Text] [Related]
17. Virus-specific effects of recombinant porcine interferon-gamma and the induction of Mx proteins in pig cells.
Horisberger MA
J Interferon Res; 1992 Dec; 12(6):439-44. PubMed ID: 1337754
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
[TBL] [Abstract][Full Text] [Related]
19. Effect of exogenous tumor necrosis factor alpha, interleukin 6 and interferons on vesicular stomatitis virus replication in human placenta and amniotic membrane organ cultures.
Paradowska E; Blach-Olszewska Z; Gierlińska M; Woytoń J
Arch Immunol Ther Exp (Warsz); 1996; 44(1):57-62. PubMed ID: 8874771
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competent rats.
Shinozaki K; Ebert O; Suriawinata A; Thung SN; Woo SL
J Virol; 2005 Nov; 79(21):13705-13. PubMed ID: 16227290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
